Pancoast syndrome due to pulmonary metastasis of sarcomatoid hepatocellular carcinoma

Keywords: Hepatectomy, Pancoast syndrome, sarcoma INTRODUCTION Primary liver cancer is the fifth most common prevalent cancer and the third commonest cause of cancer-attributed mortality.1 Hepatocellular carcinoma (HCC) is the principal histological type of liver cancer and accounts for about 75% of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Malaysian journal of pathology 2023-08, Vol.45 (2), p.285-292
Hauptverfasser: Hoo, Ryan, Shelat, Vishalkumar G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 292
container_issue 2
container_start_page 285
container_title Malaysian journal of pathology
container_volume 45
creator Hoo, Ryan
Shelat, Vishalkumar G
description Keywords: Hepatectomy, Pancoast syndrome, sarcoma INTRODUCTION Primary liver cancer is the fifth most common prevalent cancer and the third commonest cause of cancer-attributed mortality.1 Hepatocellular carcinoma (HCC) is the principal histological type of liver cancer and accounts for about 75% of liver cancers.2 Sarcomatoid hepatocellular carcinoma (SHC) is a rare form of HCC comprising of epithelial cells and mesenchymal spindle cells which makes up for about 1.8-3.9% of HCC cases.3 The most common site of metastasis for HCC is the lung4, and SHC metastasis to the lung is also reported.5 Despite the prevalence of liver cancer metastasis to the lung, according to our research there are only four Pancoast syndrome reports from primary HCC related pulmonary metastases, and none from SHC69 In this case report, a patient with known history of SHC presented with symptoms of Pancoast Syndrome due to pulmonary metastasis of SHC 5 months after hepatic resection. The standardised liver volume based on 62.0 kg body weight was 1047.0 ml. [...]residual liver volume to standardised liver volume ratio was 52.1%. Sarcomatoid change in HCC is defined as "sarcomatous HCC" in the World Health Organization (WHO) classification.10 The diagnosis of SHC should be made when a sarcomatous component consisting of malignant spindle cells11 is present within a conventional HCC. SHC cases have been reported after anticancer therapy of HCC such as transcatheter arterial chemoembolisation (TACE), radiofrequency ablation (RFA), or percutaneous ethanol injection as these therapies may speed up proliferation of sarcomatous cells."¦13 SHC is also associated with Hepatitis B and Hepatitis C infections.14 In many instances the diagnosis of SHC is made after surgical resection, and pre-operative diagnosis by MRI and CT scan imaging lacks sensitivity.15 In our patient, the sarcomatoid component consisted of malignant spindle cells that merged with areas of conventional HCC.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2860404509</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2860404509</sourcerecordid><originalsourceid>FETCH-LOGICAL-p216t-61bff903a7857f49e02bdd71c5ebe413a3e54028d80f9714b20b268b16b2dcb83</originalsourceid><addsrcrecordid>eNpdjjtLBDEYRVMouK7-h4CNzcCXx2SSUhZfIGjh1kueOMtMMiaZYv-9WbSyuhfu4XIu0AYIFZ0UrL9C16UcAQRXSm7Q_kNHm3SpuJyiy2n22K0e14SXdZpT1PmEZ18boMtYcAq46GzTrGsaHf7ySyvWT9M66Yxtm8bYxht0GfRU_O1fbtH-6fFz99K9vT-_7h7euoUSUTtBTAgKmB5kPwSuPFDj3EBs743nhGnmew5UOglBDYQbCoYKaYgw1Fkj2Rbd__4uOX2vvtTDPJazjo4-reVApQAOvAfV0Lt_6DGtOTa7MyVhAOCc_QBtL1si</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2868070044</pqid></control><display><type>article</type><title>Pancoast syndrome due to pulmonary metastasis of sarcomatoid hepatocellular carcinoma</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Hoo, Ryan ; Shelat, Vishalkumar G</creator><creatorcontrib>Hoo, Ryan ; Shelat, Vishalkumar G</creatorcontrib><description>Keywords: Hepatectomy, Pancoast syndrome, sarcoma INTRODUCTION Primary liver cancer is the fifth most common prevalent cancer and the third commonest cause of cancer-attributed mortality.1 Hepatocellular carcinoma (HCC) is the principal histological type of liver cancer and accounts for about 75% of liver cancers.2 Sarcomatoid hepatocellular carcinoma (SHC) is a rare form of HCC comprising of epithelial cells and mesenchymal spindle cells which makes up for about 1.8-3.9% of HCC cases.3 The most common site of metastasis for HCC is the lung4, and SHC metastasis to the lung is also reported.5 Despite the prevalence of liver cancer metastasis to the lung, according to our research there are only four Pancoast syndrome reports from primary HCC related pulmonary metastases, and none from SHC69 In this case report, a patient with known history of SHC presented with symptoms of Pancoast Syndrome due to pulmonary metastasis of SHC 5 months after hepatic resection. The standardised liver volume based on 62.0 kg body weight was 1047.0 ml. [...]residual liver volume to standardised liver volume ratio was 52.1%. Sarcomatoid change in HCC is defined as "sarcomatous HCC" in the World Health Organization (WHO) classification.10 The diagnosis of SHC should be made when a sarcomatous component consisting of malignant spindle cells11 is present within a conventional HCC. SHC cases have been reported after anticancer therapy of HCC such as transcatheter arterial chemoembolisation (TACE), radiofrequency ablation (RFA), or percutaneous ethanol injection as these therapies may speed up proliferation of sarcomatous cells."¦13 SHC is also associated with Hepatitis B and Hepatitis C infections.14 In many instances the diagnosis of SHC is made after surgical resection, and pre-operative diagnosis by MRI and CT scan imaging lacks sensitivity.15 In our patient, the sarcomatoid component consisted of malignant spindle cells that merged with areas of conventional HCC.</description><identifier>ISSN: 0126-8635</identifier><language>eng</language><publisher>Kuala Lumpur: College of Pathologists, Academy of Medicine of Malaysia</publisher><subject>Abdomen ; Antigens ; Brachial plexus ; Cancer therapies ; Case reports ; Hepatitis B ; Liver cancer ; Lung cancer ; Magnetic resonance imaging ; Medical imaging ; Metastasis ; Multidisciplinary teams ; Serology ; Shoulder ; Surgery ; Tomography</subject><ispartof>Malaysian journal of pathology, 2023-08, Vol.45 (2), p.285-292</ispartof><rights>Copyright College of Pathologists, Academy of Medicine of Malaysia Aug 2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Hoo, Ryan</creatorcontrib><creatorcontrib>Shelat, Vishalkumar G</creatorcontrib><title>Pancoast syndrome due to pulmonary metastasis of sarcomatoid hepatocellular carcinoma</title><title>Malaysian journal of pathology</title><description>Keywords: Hepatectomy, Pancoast syndrome, sarcoma INTRODUCTION Primary liver cancer is the fifth most common prevalent cancer and the third commonest cause of cancer-attributed mortality.1 Hepatocellular carcinoma (HCC) is the principal histological type of liver cancer and accounts for about 75% of liver cancers.2 Sarcomatoid hepatocellular carcinoma (SHC) is a rare form of HCC comprising of epithelial cells and mesenchymal spindle cells which makes up for about 1.8-3.9% of HCC cases.3 The most common site of metastasis for HCC is the lung4, and SHC metastasis to the lung is also reported.5 Despite the prevalence of liver cancer metastasis to the lung, according to our research there are only four Pancoast syndrome reports from primary HCC related pulmonary metastases, and none from SHC69 In this case report, a patient with known history of SHC presented with symptoms of Pancoast Syndrome due to pulmonary metastasis of SHC 5 months after hepatic resection. The standardised liver volume based on 62.0 kg body weight was 1047.0 ml. [...]residual liver volume to standardised liver volume ratio was 52.1%. Sarcomatoid change in HCC is defined as "sarcomatous HCC" in the World Health Organization (WHO) classification.10 The diagnosis of SHC should be made when a sarcomatous component consisting of malignant spindle cells11 is present within a conventional HCC. SHC cases have been reported after anticancer therapy of HCC such as transcatheter arterial chemoembolisation (TACE), radiofrequency ablation (RFA), or percutaneous ethanol injection as these therapies may speed up proliferation of sarcomatous cells."¦13 SHC is also associated with Hepatitis B and Hepatitis C infections.14 In many instances the diagnosis of SHC is made after surgical resection, and pre-operative diagnosis by MRI and CT scan imaging lacks sensitivity.15 In our patient, the sarcomatoid component consisted of malignant spindle cells that merged with areas of conventional HCC.</description><subject>Abdomen</subject><subject>Antigens</subject><subject>Brachial plexus</subject><subject>Cancer therapies</subject><subject>Case reports</subject><subject>Hepatitis B</subject><subject>Liver cancer</subject><subject>Lung cancer</subject><subject>Magnetic resonance imaging</subject><subject>Medical imaging</subject><subject>Metastasis</subject><subject>Multidisciplinary teams</subject><subject>Serology</subject><subject>Shoulder</subject><subject>Surgery</subject><subject>Tomography</subject><issn>0126-8635</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdjjtLBDEYRVMouK7-h4CNzcCXx2SSUhZfIGjh1kueOMtMMiaZYv-9WbSyuhfu4XIu0AYIFZ0UrL9C16UcAQRXSm7Q_kNHm3SpuJyiy2n22K0e14SXdZpT1PmEZ18boMtYcAq46GzTrGsaHf7ySyvWT9M66Yxtm8bYxht0GfRU_O1fbtH-6fFz99K9vT-_7h7euoUSUTtBTAgKmB5kPwSuPFDj3EBs743nhGnmew5UOglBDYQbCoYKaYgw1Fkj2Rbd__4uOX2vvtTDPJazjo4-reVApQAOvAfV0Lt_6DGtOTa7MyVhAOCc_QBtL1si</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Hoo, Ryan</creator><creator>Shelat, Vishalkumar G</creator><general>College of Pathologists, Academy of Medicine of Malaysia</general><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BVBZV</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20230801</creationdate><title>Pancoast syndrome due to pulmonary metastasis of sarcomatoid hepatocellular carcinoma</title><author>Hoo, Ryan ; Shelat, Vishalkumar G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p216t-61bff903a7857f49e02bdd71c5ebe413a3e54028d80f9714b20b268b16b2dcb83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Abdomen</topic><topic>Antigens</topic><topic>Brachial plexus</topic><topic>Cancer therapies</topic><topic>Case reports</topic><topic>Hepatitis B</topic><topic>Liver cancer</topic><topic>Lung cancer</topic><topic>Magnetic resonance imaging</topic><topic>Medical imaging</topic><topic>Metastasis</topic><topic>Multidisciplinary teams</topic><topic>Serology</topic><topic>Shoulder</topic><topic>Surgery</topic><topic>Tomography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hoo, Ryan</creatorcontrib><creatorcontrib>Shelat, Vishalkumar G</creatorcontrib><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>East &amp; South Asia Database</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Malaysian journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hoo, Ryan</au><au>Shelat, Vishalkumar G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pancoast syndrome due to pulmonary metastasis of sarcomatoid hepatocellular carcinoma</atitle><jtitle>Malaysian journal of pathology</jtitle><date>2023-08-01</date><risdate>2023</risdate><volume>45</volume><issue>2</issue><spage>285</spage><epage>292</epage><pages>285-292</pages><issn>0126-8635</issn><abstract>Keywords: Hepatectomy, Pancoast syndrome, sarcoma INTRODUCTION Primary liver cancer is the fifth most common prevalent cancer and the third commonest cause of cancer-attributed mortality.1 Hepatocellular carcinoma (HCC) is the principal histological type of liver cancer and accounts for about 75% of liver cancers.2 Sarcomatoid hepatocellular carcinoma (SHC) is a rare form of HCC comprising of epithelial cells and mesenchymal spindle cells which makes up for about 1.8-3.9% of HCC cases.3 The most common site of metastasis for HCC is the lung4, and SHC metastasis to the lung is also reported.5 Despite the prevalence of liver cancer metastasis to the lung, according to our research there are only four Pancoast syndrome reports from primary HCC related pulmonary metastases, and none from SHC69 In this case report, a patient with known history of SHC presented with symptoms of Pancoast Syndrome due to pulmonary metastasis of SHC 5 months after hepatic resection. The standardised liver volume based on 62.0 kg body weight was 1047.0 ml. [...]residual liver volume to standardised liver volume ratio was 52.1%. Sarcomatoid change in HCC is defined as "sarcomatous HCC" in the World Health Organization (WHO) classification.10 The diagnosis of SHC should be made when a sarcomatous component consisting of malignant spindle cells11 is present within a conventional HCC. SHC cases have been reported after anticancer therapy of HCC such as transcatheter arterial chemoembolisation (TACE), radiofrequency ablation (RFA), or percutaneous ethanol injection as these therapies may speed up proliferation of sarcomatous cells."¦13 SHC is also associated with Hepatitis B and Hepatitis C infections.14 In many instances the diagnosis of SHC is made after surgical resection, and pre-operative diagnosis by MRI and CT scan imaging lacks sensitivity.15 In our patient, the sarcomatoid component consisted of malignant spindle cells that merged with areas of conventional HCC.</abstract><cop>Kuala Lumpur</cop><pub>College of Pathologists, Academy of Medicine of Malaysia</pub><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0126-8635
ispartof Malaysian journal of pathology, 2023-08, Vol.45 (2), p.285-292
issn 0126-8635
language eng
recordid cdi_proquest_miscellaneous_2860404509
source EZB-FREE-00999 freely available EZB journals
subjects Abdomen
Antigens
Brachial plexus
Cancer therapies
Case reports
Hepatitis B
Liver cancer
Lung cancer
Magnetic resonance imaging
Medical imaging
Metastasis
Multidisciplinary teams
Serology
Shoulder
Surgery
Tomography
title Pancoast syndrome due to pulmonary metastasis of sarcomatoid hepatocellular carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T15%3A23%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pancoast%20syndrome%20due%20to%20pulmonary%20metastasis%20of%20sarcomatoid%20hepatocellular%20carcinoma&rft.jtitle=Malaysian%20journal%20of%20pathology&rft.au=Hoo,%20Ryan&rft.date=2023-08-01&rft.volume=45&rft.issue=2&rft.spage=285&rft.epage=292&rft.pages=285-292&rft.issn=0126-8635&rft_id=info:doi/&rft_dat=%3Cproquest%3E2860404509%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2868070044&rft_id=info:pmid/&rfr_iscdi=true